Alkasar-18

N/A

Report date: 2025/02/24 20:01:08
NME

Base Information

Drug NameAlkasar-18
Drug Alias NameNOACAlkasar-18N4-octadecyl-ara-C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA polymerase alpha subunit inhibitors
TargetsDNA polymerase alpha subunit
Therapy Area/IndicationsAtrial FibrillationCerebral HemorrhageNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Cardiovascular Diseases, China
Inactive CompaniesUniversity of ZurichPhri Population Health Research Institute International
Active IndicationsAtrial Fibrillation
Inactive IndicationsCerebral HemorrhageNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A